期刊
TRANSLATIONAL ONCOLOGY
卷 2, 期 3, 页码 138-145出版社
ELSEVIER SCIENCE INC
DOI: 10.1593/tlo.09106
关键词
-
类别
资金
- Fina Biotech, S.L
- Ministerio de Educacion y Ciencia [PET2005-0446, BFU2007-65253]
- Ministerio de Sanidad y Consumo [PI041255]
- Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) y [RET-2039]
- del ISCIII, Madrid and Comunidad de Madrid, Spain [S-GEN0269]
- Fundacion Ramon Areces
Nowadays, cellular bioenergetics has become a central issue of investigation in cancer biology. Recently, the metabolic activity of the cancer cell has been shown to correlate with a proteomic index that informs of the relative mitochondrial activity of the cell. Within this new field of investigation, we report herein the production and characterization of high-affinity monoclonal antibodies against proteins of the bioenergetic signature of the cell. The use of recombinant proteins and antibodies against the mitochondrial beta-F1-ATPase and Hsp60 proteins and the enzymes of the glycolytic pathway glyceraldehyde-3-phosphate dehydrogenase and pyruvate kinase M2 in quantitative assays provide, for the first time, the actual amount of these proteins in normal and tumor surgical specimens of breast, lung, and esophagus. The application of this methodology affords a straightforward proteomic signature that quantifies the variable energetic demand of human tissues. Furthermore, the results show an unanticipated finding: tumors from different tissues and/or histological types have the same proteomic signature of energetic metabolism. Therefore, the results indicate that cancer abolishes the tissue-specific differences in the bioenergetic phenotype of mitochondria. Overall, the results support that energetic metabolism represents an additional hallmark of the phenotype of the cancer cell and a promising target for the treatment of diverse neoplasias.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据